There are 2867 resources available
762P - Personalized immunotherapy with encapsulated cell technology: Feasibility, safety and efficacy results from the first-in-human clinical trial in advanced relapsing solid tumors
Presenter: Eugenio Fernandez
Session: Poster session 14
763P - Combined gene signature (T-cell inflamed gene expression profile – TcellinfGEP – & IMMETCOLS) identifies a metabolic rewiring program, key for immune evasion
Presenter: Helena Oliveres
Session: Poster session 14
765P - Comprehensive analysis of the association between RAS mutation and immune checkpoint marker expression
Presenter: Hirotakka Miyashita
Session: Poster session 14
766P - Levels of serum EGF concentration as biomarker of response of CIMAvax-EFG vaccine: Survival evaluation of advanced NSCLC patients treated in primary health care scenario
Presenter: Ramon Alberto Otiz Carrodeguas
Session: Poster session 14
767P - Refining patients’ selection for immunotherapeutic early-phase clinical trials (ieCTs): A single phase I unit experience
Presenter: Agnese Losurdo
Session: Poster session 14
768P - Investigation of CD73 expression in response to immunotherapy in pan-cancer
Presenter: Yonggang Wang
Session: Poster session 14
769P - Analysis of PMS2 mutation as a potential biomarker for melanoma immunotherapy
Presenter: Jiaming Qiu
Session: Poster session 14
770P - Comprehensive immune profiling of primary tumors, lymph nodes, and peripheral blood after treatment with nivolumab and BMS 986205 in head and neck squamous cell carcinoma (HNSCC)
Presenter: Larry Harshyne
Session: Poster session 14
771P - Correlation of gut microbiome composition with checkpoint inhibitor induced severe immune-related adverse events
Presenter: Rik Verheijden
Session: Poster session 14
772P - Discovery and exploration of a live bacterial consortium as co-therapy to enhance immune checkpoint inhibitor response in melanoma patients
Presenter: Mat Robinson
Session: Poster session 14